Edema
📧 Sign up to get email alerts when something new happens for Edema.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2019-11-01FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for a generic fixed-dose combination of spironolactone and hydrochlorothiazide from Sun Pharmace…
-
FDA approval · 2019-10-17FDA Approved: ACETAZOLAMIDE — Original Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' Original Application for acetazolamide, granting approval of a generic version.
-
FDA approval · 2019-09-17FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)
The FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.
-
FDA approval · 2019-09-06FDA Approved: ETHACRYNIC ACID — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals, Inc.'s Original Application for Ethacrynic acid, authorizing a generic version of the loop diuretic. Thi…
-
FDA approval · 2019-08-27FDA Approved: ETHACRYNIC ACID — Original Application (ScieGen Pharmaceuticals Inc)
FDA approved Ethacrynic acid from ScieGen Pharmaceuticals Inc under an Original Application (ANDA211232).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-08-06FDA Approved: CHLORTHALIDONE — Original Application (Unichem Pharmaceuticals (USA), Inc.)
FDA approved the original application for chlorthalidone from Unichem Pharmaceuticals (USA), Inc., enabling a generic version of the diureti…
-
FDA approval · 2019-08-05FDA Approved: SPIRONOLACTONE — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for spironolactone, enabling the marketing of a new generic product.
-
FDA approval · 2019-07-25FDA Approved: SPIRONOLACTONE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for spironolactone submitted by Sun Pharmaceutical Industries, Inc., indicating an update to the…
-
FDA approval · 2019-07-01FDA Approved: CHLORTHALIDONE — Original Application (Amneal Pharmaceuticals LLC)
The FDA approved Amneal Pharmaceuticals LLC's original application for chlorthalidone, a thiazide-like diuretic used to treat hypertension a…
-
FDA approval · 2019-05-10FDA Approved: CHLORTHALIDONE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for chlorthalidone from Zydus Lifesciences Limited, granting generic approval under ANDA207813.
-
FDA approval · 2019-05-03FDA Approved: FUROSEMIDE — Original Application (Eugia US LLC)
FDA approved an original ANDA for FUROSEMIDE by Eugia US LLC, confirming a generic version of the diuretic. This is a routine generic drug a…
-
FDA approval · 2019-04-24FDA Approved: BUMETANIDE — Supplemental Application (Upsher-Smith Laboratories, LLC)
The FDA approved a supplemental application for Bumetanide from Upsher-Smith Laboratories, LLC.
-
FDA approval · 2019-02-26FDA Approved: CHLORTHALIDONE — Original Application (Chartwell RX, LLC)
The FDA approved Chartwell RX, LLC's original application for chlorthalidone, a generic diuretic. This enables marketing of the generic chlo…
-
FDA approval · 2019-02-11FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Lifesciences Limited)
FDA approved the original application for a generic Triamterene and Hydrochlorothiazide tablet from Zydus Lifesciences Limited.
-
FDA approval · 2019-01-17FDA Approved: SPIRONOLACTONE AND HYDROCHLOROTHIAZIDE — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for Spironolactone and Hydrochlorothiazide from Prasco Laboratories, authorizing changes to the prod…
-
FDA approval · 2019-01-14FDA Approved: HYDROCHLOROTHIAZIDE — Original Application (ScieGen Pharmaceuticals Inc)
The FDA approved ScieGen Pharmaceuticals' original application for hydrochlorothiazide, making this generic diuretic available in the United…
-
FDA approval · 2018-10-12FDA Approved: CHLORTHALIDONE — Original Application (Dr. Reddy's Laboratories Inc.)
FDA approved Dr. Reddy's Laboratories Inc.'s original application for chlorthalidone (generic diuretic) under ANDA210742.
-
FDA approval · 2018-08-08FDA Approved: LASIX — Supplemental Application (Validus Pharmaceuticals LLC)
FDA approved a supplemental application for LASIX (furosemide) from Validus Pharmaceuticals LLC.
-
FDA approval · 2018-07-18FDA Approved: SPIRONOLACTONE — Original Application (Zydus Lifesciences Limited)
FDA approved the Original Application (ANDA) for spironolactone from Zydus Lifesciences Limited, marking a generic version of the diuretic.
-
FDA approval · 2018-06-29FDA Approved: TRIAMTERENE AND HYDROCHLOROTHIAZIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved the original application for Triamterene and Hydrochlorothiazide from Zydus Pharmaceuticals (USA) Inc., a generic fixed-dose co…
-
FDA approval · 2018-05-24FDA Approved: CHLORTHALIDONE — Original Application (Nivagen Pharmaceuticals, INC.)
FDA approved CHLORTHALIDONE from Nivagen Pharmaceuticals as an original generic application.
-
FDA approval · 2018-05-08FDA Approved: ETHACRYNIC ACID — Original Application (Amneal Pharmaceuticals NY LLC)
FDA approved the original generic application for Ethacrynic acid from Amneal Pharmaceuticals NY LLC.
-
FDA approval · 2018-04-30FDA Approved: BUMETANIDE — Original Application (Zydus Pharmaceuticals (USA) Inc.)
FDA approved Bumetanide as a generic via Original Application (ANDA 202900), confirming bioequivalence to the reference product. It is indic…
-
FDA approval · 2018-04-19FDA Approved: THALITONE — Supplemental Application (Casper Pharma LLC)
FDA approved a supplemental application for THALITONE (chlorthalidone) submitted by Casper Pharma LLC.
-
FDA approval · 2017-09-22FDA Approved: INDAPAMIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for Indapamide (ANI Pharmaceuticals), updating its regulatory approval.